2026 SPEAKERS
Alisha Smith
Clinical Operations Director, Dimerix, Australia
Bryce Davies
Head of APAC Early Phase Oncology and Innovative Therapies Strategy, IQVIA Biotech
Dr Mohammed Alsharifi
Chief Scientific Officer, Gamma Vaccines, Australia
Hemasunder Reddy (Hem)
Director, Asia Pacific, Pfanstiehl
Micheal Schafferius
Product Specialist for Filtration Asia (ex-China), Sartorius
Paul Rolan
Chief Medical Officer, GPN Vaccines, Australia
Tam Nguyen
Director Research & Innovation, Monash Health, Australia
Xenia Sango
Chief Executive Officer & Managing Director, VivaZome Therapeutics, Australia
Priyanka Agarwal
Director of Research and Operations , TheiaNova, New Zealand
Shaun McColl
CSO, Carina Biotech, Australia
Glenn Pilkington
Director, Clinical Development, NeuClone
Renee Winzar
Senior Manager, Development, ACAMI, La Trobe University
Peter Tobin
VP, Head of Translational Medicine, Telix Pharmaceuticals
Michelle Ferrari Cestari
Co-Founder & Managing Director, JM Clinical
Omar Dabash
Chief Scientific Officer & Co-founder, Oncoparse, Australia
Kuldip Sidhu
Executive Director & Chief Scientific Officer, CK Cell Technologies, Australia
Andrew Venables
Chief Executive Officer, Loxegen, Australia
Deborah Rathjen
Chief Executive Officer, Carina Biotech, Australia
Gavin Currie
CEO, Biosceptre, Australia
Gisela Mautner
CEO & Managing Director, Noxopharm, Australia
Gregory Rice
Chief Scientific Officer, INOVIQ, Australia
Jolanta Airey
Chief Medical Officer, Cynata Therapeutics, Australia
Joseph Torresi
NHMRC Practitioner Fellow, Department of Microbiology and Immunology, Australia
Julie Monk
Director Clinical Development, RAGE Biotech, Australia
Kiran Shah
Head Scientific Officer, Magellan Stem Cells, Australia
Lana Gregory
Senior Manager, Regulatory Sciences, Moderna Australia & New Zealand
Leab Sek
Associate Director, Global Regulatory Sciences CMC, Moderna, Australia
Leslie Chong
CEO and Managing Director, Imugene, Australia
Lisa Bonadonna
Director, Cumming Global Centre for Pandemic Therapeutics, Australia
Michael Baker
CEO & MD, Arovella Therapeutics, Australia
Nicholas Bliesner
Chief Operating Officer, Magellan Stem Cells, Australia
Oksana Zdanska
Medical Director, ImmVirX, Australia
Olivier Briand
Head of mRNA Global Clinical Manufacturing, Sanofi, France
Paul McDonald
Chief Executive Office, RNA Australia
Phoebe Dunn
Chief Executive Officer, mRNA Victoria, Australia
Robert Caunce
Director, Quality, IDT Australia
Rosanne Dunn
Director & Chief Scientific Officer, HaemaLogiX, Australia
Silvio Tiziani
Chief Executive Officer, CCRM Australia, Australia
Tim Oldham
CEO and Managing Director, AdAlta, Australia
Walid Azar
Chief Scientific Officer, Cartherics, Australia
Milica Ng
Biomedical Data Science Executive, ex- CSL
Ciaran O’Keeffe
Regional Sales Director, MasterControl
Seth Cheetham
Director, National Biologics Facility
Silviu Itescu
CEO, Mesoblast, Australia
Madeline Cao
Head of Manufacturing Development, Cartherics, Australia
Rachel Yoon Chang
Facility Lead, BASE, UQ, Australia
Blaz Bakalar
Business Development Manager, BIA Management, Sartorius
Antiksha Joshi
Director of Quality, GPN Vaccines, Australia
Marc Fini
Executive Director, Strategic Projects, RNA Australia
Associate Professor Shayanti Mukherjee
Head, Translational Tissue Engineering Lab, The Ritchie Centre, Hudson Institute of Medical Research
Jan Bekker
Vice President, Business Development & Commercial Operations, BioCina
For Speaking Opportunities, Kindly Contact:
Share With Your Network
